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as the amount of ligands associated with bRs I, II, and III (100TGF-b receptor expression and binding in rat mesangial cells:
to 250%). This same treatment also increased the levels of bRIModulation by glucose and cyclic mechanical strain.
and bRII mRNA (30 to 40%) and the immunoreactive proteinBackground. Transforming growth factor-b (TGF-b) is a
(82 and 82%, respectively), without significantly altering thecausal factor in experimental glomerulosclerosis, and it medi-
binding affinity of the receptor. A concerted or synergisticates the increased extracellular matrix (ECM) accumulation
effect of both stimuli was not evidenced.that occurs in cultured mesangial cells (MCs) exposed to high
Conclusion. These results suggest that the modulation ofglucose concentrations and cyclic mechanical strain. This change
TGF-b receptors may be an additional control point in mediat-is associated with increased levels of TGF-b, but may also
ing the glucose- and mechanical force-induced increase in ECMinvolve alterations in receptor expression and binding.
deposition by MCs.Methods. Rat MCs cultured in media containing either 8 or
35 mm glucose were seeded into culture plates with elastin-
coated flexible bottoms. Thereafter, they were subjected to cyclic
Transforming growth factor-b (TGF-b) is a family ofstretch or static conditions and then examined for 125I-TGF-b1
binding and expression of TGF-b receptors at the gene and cytokines that, in mammals, includes TGF-bs 1, 2, and 3.
protein levels. They possess autocrine and paracrine multifunctional ac-
Results. Kinetic studies showed that MCs bound TGF-b1 in tivities, one of which is the stimulation of extracellular
a time- and concentration-dependent manner, expressing 6800 matrix (ECM) synthesis. This function, although essentialhigh-affinity receptors per cell, with an apparent dissociation
for wound healing, is also responsible for mediating fibro-constant (Kd) of 15.4 pm, while cross-linking analysis identified
sis and scarring when not down-regulated at the termina-three TGF-b receptors (bR) corresponding to bRI, bRII, and
bRIII of 54, 73, and 200 kDa, respectively. Immunocytochemi- tion of normal tissue repair [1]. Such a pathogenetic role
cal studies of bRI and bRII protein revealed MC expression of TGF-b has been convincingly demonstrated in a num-
in a homogeneous, punctate distribution, whereas Northern anal- ber of experimental models of renal glomerulosclerosis
ysis demonstrated the presence of the corresponding mRNAs. [2–4] and is likely causal in certain forms of this disorder
Exposure to cyclic stretching significantly increased (10%) the
in humans, including that associated with diabetes [5, 6].overall number of TGF-b receptors, whereas ligands associated
The factors responsible for both inducing and sus-with bRs I, II, and III also increased (25 to 50%). The finding
taining the increased TGF-b activity in diabetic glomeru-of increased (30 to 40%) bRI and bRII transcript levels and
immunoreactive protein (163 and 59%, respectively) in the losclerosis are now beginning to emerge. For example,
absence of significant changes in the apparent Kd indicated that the incubation of cultured mesangial cells (MCs) in me-
stretch-induced binding was the result of increased receptor dia containing increased glucose levels, simulating the
synthesis and expression and not due to a change in binding hyperglycemic environment, induces TGF-b secretionaffinity. In a similar, but more dramatic fashion, exposure to
and ECM accumulation [7–10]. In addition, inhibition ofhigh glucose also elevated (50%) the receptor number, as well
this TGF-b activity significantly reduces the high-glucose–
mediated induction of matrix synthesis [10]. The effect
of TGF-b on MC formation of ECM is of significanceKey words: cell elasticity, transforming growth factor-b, extracellular
matrix, fibrosis, scarring, tissue repair, glomerulosclerosis, diabetic kid- because these cells are largely responsible for the in situ
ney disease. mesangial matrix synthesis and increased deposition ob-
served in diabetic glomerulosclerosis [11, 12].Received for publication July 31, 1998
Another factor that may be important in stimulatingand in revised form January 22, 1999
Accepted for publication March 3, 1999 and maintaining high TGF-b levels is the mechanical
strain resulting from altered glomerular hemodynamics. 1999 by the International Society of Nephrology
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Simulating in tissue culture the effects of increased glo- sure to high-glucose medium and/or mechanical strain
merular distention, we have shown that cyclic cell stretch- on TGF-b receptor expression and binding.
ing of MCs induces both increased production and activ-
ity of TGF-b1 [13], as well as synthesis and accumulation
METHODSof mesangial matrix components [14]. This stimulation
Mesangial cellsof TGF-b1 activity is manifested as an increase in mRNA
levels, secretion of protein, and the activation of the Cells, which we previously characterized and described
latent molecule. Furthermore, the response is specific [26], were obtained from a cloned line derived from
for this cytokine because the activities of tumor necrosis outgrowths of Fischer rat glomeruli. These cells continue,
factor-a (TNF-a), interleukin-1 (IL-1), and even TGF-b2 with serial passage, to express markers of MCs, including
remain unchanged [13]. We have also shown that the characteristic morphology, ability to grow in media con-
induction of TGF-b1 activity and collagen accumulation taining D-valine, and growth inhibition in the presence
by stretch is further enhanced in the presence of in- of heparin or mitomycin. They additionally express the
creased glucose concentrations [15]. Finally, the marked Thy-1 antigen and demonstrate the same high sensitivity
increase in collagen accumulation that occurs under to phorbol-stimulated neutrophil adhesion and lysis as
these conditions is reversed by the action of a TGF-b– do early passage MCs, indicating continued expression
neutralizing antibody [15]. of essential cell surface receptors [27]. Stock cultures
An important factor in the cascade of events leading were propagated in the growth medium RPMI 1640,
to augmented ECM production may also be changes in containing antibiotics, 20% Nu-Serum (Collaborative
TGF-b receptors. TGF-b1 and TGF-b3 mediate their Research, Bedford, MA, USA), and 8 mm glucose.
activity by binding to the TGF-b type II receptor (bRII),
a constitutively active transmembrane serine/threonine Tissue culture
kinase [16]. This receptor recruits and then phosphory- Mesangial cells were seeded (5 3 104 cells/25 mm di-
lates another transmembrane kinase, the TGF-b recep- ameter well) into six-well plates with flexible elastin-
tor bRI [17], resulting in ternary complex formation and coated bottoms (Flex I plates; Flexcell International, Mc-
signaling. The TGF-b type III receptor (bRIII) betagly- Keesport, PA, USA) and cultured in 1 ml/well of growth
can is a membrane protein that increases the binding of medium. After either 24 or 48 hours of incubation, exper-
TGF-bs 1 and 3 to the signaling receptors and may be imental cultures were subjected to cyclic stretching, and
necessary for equivalent TGF-b2 binding [18]. Changes the control cultures were maintained in a static environ-
in expression and/or binding of one or more of these ment under identical conditions. During this final period,
receptors could then conceivably alter the biological re-
cells were maintained in medium containing 1% fetalsponse, irrespective of changes in the quantity of avail-
calf serum (FCS). Stretch was mediated by controlledable active TGF-b.
cycles of vacuum applied to the underside of the flexible-Although little is currently known about the regulation
bottom culture well, using a computer-assisted systemof TGF-b binding, it has been demonstrated that cell
(Flexercell Strain Unitt; Flexcell International). Thisdensity [19], as well as exposure to adrenocorticotropic
system provides precisely timed, negative pressure cycleshormone [20], interferon-g [21], prostaglandin E2 [22],
of known magnitude, deforming the bottom of the cultureor exogenous TGF-b [23]. can result in altered TGF-b
well and stretching the cells attached to its surface. Inbinding in certain cell types. In the rodent kidney, there
an attempt to mimic conditions of MC stretch duringis an up-regulation in mRNA levels of bRII following
possible low-frequency oscillations in intraglomerularthe induction of diabetes with streptozotocin [24] and of
pressure [28], all experiments were carried out usingbRII and bRIII message levels in adriamycin-induced
alternating cycles of 10-second stretch and 10-secondnephrosclerosis [25]. However, the regulation of TGF-b
relaxation (50 mHz). Vacuum intensity was set to pro-binding in cultured MCs has not been examined. We
vide an average elongation of approximately 8% overhave previously reported that in cultures of MCs exposed
the entire culture surface [29]. Under these mechanicalto a gradient of stretching amplitude, only those cells
conditions, cellular proliferation was unaffected.subjected to significant mechanical strain demonstrate
In experiments in which the effect of high glucose con-intense immunostaining for the active form of TGF-b,
centration was studied, cells that had been maintainedas opposed to those in the same culture experiencing
in medium containing 8 mm glucose were dispersed andlittle or no strain [13]. This differential localization of
then cultured for seven to eight days in the presenceactive TGF-b occurs even though the conditioned media
of either 8 or 35 mm glucose. Cells were subsequentlybathing all cells contains greatly increased amounts of
dispersed and reseeded in equal densities on Flex I platesthis factor, as compared with unstretched control cul-
and cultures continued in the same 8 or 35 mm glucosetures. This suggests the possibility that TGF-b binding
media for an additional two to four days. Although 8 mmis increased in response to cyclic strain. This study was
therefore carried out to determine the effects of expo- glucose is higher than “normal physiological” levels
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(5 mm), it is substantially lower than those found in usual solubilized, and the suspension was counted. Specific
TGF-b binding was determined from bound versus freeculture media (11 mm) and is the minimal concentration
required for long-term growth of these cells. radioactivity after subtracting the amount of nonspecifi-
cally bound ligand. Specific binding accounted for 60 to
Analysis of mRNA 70% of the total bound radioactivity.
Cross-linking was used to determine specific bindingRNA was isolated by a modified guanidinium method
in RNA Stat-60 reagent (Tel-Test Inc., Friendswood, to TGF-b receptor isoforms. In this case, assays were
performed as described earlier in this article, except thatTX, USA). Samples were denatured in glyoxal/dimethyl-
sulfoxide (DMSO) at 558C for 60 minutes and 20 mg of wells were incubated with 100 pm radiolabeled or radio-
labeled plus unlabeled TGF-b1 (10 mm). Following atotal RNA electrophoresed on 10 mm sodium phosphate/
1% agarose gels. Gels were then stained with ethidium two-hour incubation at 48C, the medium was removed,
and the bound ligand was cross-linked to receptors bybromide (5 ml/ml) and photographed, and the separated
RNAs were transferred to Genescreen membranes (NEN adding cold binding buffer containing 30 mm disuccinimi-
dyl suberate (DSS; Pierce Chemical Co., Rockford, IL,Research, DuPont Co., Boston, MA, USA) by capillary
action using standard methods [30]. The blots were hybrid- USA) freshly dissolved in DMSO. The samples were then
incubated at 48C for 15 minutes with gentle rocking, andized and probed for individual TGF-b receptor mRNAs
using the corresponding cDNAs that were 32P-labeled the reaction was terminated by three washes with a solu-
tion of 250 mm sucrose, 10 mm Tris, and 1 mm ethylenedi-by random hexamer priming (Sigma Prime-1 kit; Sigma
Chemical Co., St. Louis, MO, USA). Autoradiograms aminetetraacetic acid (EDTA) to quench the remaining
cross-linker. Cells and matrix were then solubilized bywere digitized by scanning densitometry (Scanmaster 31
Densitometer; Howtek, Hudson, NH, USA) and quanti- the addition of lysis buffer (as described), containing pro-
tease inhibitors phenylmethylsulfonyl fluoride (PMSF)tated with image analysis (vs. 1.59, Twilight Clone BBS;
NIH Image, Silver Springs, MD). The assayed TGF-b 1 mm, Nahrungs Einheit Milch (NEM; milk nutritional
unit) 40 mm, and EDTA 1 mm. Samples were centrifugedreceptor mRNAs were normalized to rRNA (18S and
28S) to adjust for differences in loading. The probe for at 13,000 3 g for two minutes, and supernatants were
collected and boiled for two minutes in 1 3 LaemmlibRI was an Xba I fragment of the rat activin receptor-
like kinase 5 (ALK5) and hybridized to a 6.0 kb tran- buffer [33]. Lysate volumes were adjusted for protein
content and then electrophoresed on 4 to 10% sodiumscript. The bRII probe was a 2.8 kb rat full-length bRII
cDNA that hybridizes with a 5.5 kb mRNA. We pro- dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) gels and autoradiographed. Band intensities wereduced both probes, which have both been previously
characterized [31]. determined by scanning densitometry, as described ear-
lier here.
Transforming growth factor-b binding assays
Immunocytochemistry for transforming growthTransforming growth factor-b1 was iodinated using
factor-b receptorsthe modified chloramine T procedure of Frolik et al
[32]. This method generated iodinated TGF-b1 with high Mesangial cells cultured on elastin-coated bottoms
Flex I plates were removed from 378C and washed usingspecific activity (100 to 150 mCi/mg) that retained its
ability to interact with the cell. All assays were performed an infinite dilution protocol. In brief, approximately one
half of the culture media were removed from each well,within two weeks of iodination. Binding assays were
performed when cells were 90 to 95% confluent, approxi- and an equivalent amount of phosphate-buffered saline
(PBS) at 378C was added. This procedure was repeatedmately 4 days after seeding. The medium was aspirated,
and cultures were incubated for two minutes at 48C in several times until all traces of media were removed. In
the same manner, half of the PBS was removed anda 20 mm glycine buffer (pH 3) containing 135 mm NaCl
to remove endogenous TGF-b. After two rinses with replaced with 378C, 4% (wt/vol) paraformaldehyde in
0.1 m Na Cacodylate buffer, pH 7.4 (both Sigma), againbinding buffer [Dulbecco’s modified Eagle’s medium
(DMEM), 25 mm HEPES, 1% bovine serum albumin using multiple changes, after which cells were fixed for
30 minutes at room temperature. Samples were then(BSA)], 125I-labeled TGF-b1 was added to the buffer to
achieve final concentrations ranging from 2 to 200 pm. washed with PBT (PBS plus 0.1% Triton X-100) to pro-
mote internalization of antibodies. Cells were blockedNonspecific binding was determined in wells containing
100-fold or greater excess of unlabeled TGF-b1. Follow- with diluted goat serum (1:200) and incubated with pri-
mary antibodies diluted 1:100 in PBT with 0.5% BSAing incubation at 228C with gentle rotation, the medium
was removed for determination of free radioactivity. The overnight at 48C with gentle rocking. Cells were again
washed with PBT and incubated overnight at 48C incells were then quickly washed twice with binding buffer
and with 1% Triton X-100, containing 10% glycerol, goat ant-rabbit IgG conjugated to Cy3 (Amersham Life
Sciences, Arlington Heights, IL, USA) diluted 1:200 in20 mm HEPES, and 0.01% BSA. Triplicate samples were
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PBS containing 0.5% BSA. After washing, MCs were
covered with 5% N-propyl gallate in glycerol, and cover
slips were applied. Cells were viewed with a BioRad 1024
(Bio-Rad, Hercules, CA, USA) laser scanning confocal
microscope. Digitized 8-bit images from representative
areas of the culture membrane were obtained under
identical conditions of laser intensity and gain and were
a composite of the fluorescent signal from 0.5 mm serial
sections. The images from each culture were divided
into quadrants and separately analyzed under identical
density calibration, and the quantity of fluorescence was
determined using image analysis (NIH Image), as we
have previously described [13]. Negative controls con-
sisted of replacement of the primary antibody with non-
immune rabbit IgG and preincubation of the antibodies
with a 10 m excess of peptide antigen. All controls were Fig. 1. Time course of 125I-TGF-b1 binding to mesangial cells (MCs).
The values represent the average of specifically bound transformingwithout detectable immunostaining. Antibodies to bRI
growth factor-b1 (TGF-b1) at each time point, based on triplicate wellswere purchased from Santa Cruz Biotechnology (Santa in a single experiment. All values were within 10% of the average values.
Cruz, CA, USA). The bRI antibody (cat. no. SC 399)
was raised against a peptide corresponding to amino
acids 482 to 501 mapping at the carboxy terminus of the
bRI (also designated ALK-5) of human origin and which 1 to 35 pm (free molecule) and was saturable (Fig. 2).
High-glucose treatment increased the amount of TGF-b1is homologous to the corresponding rat primary sequence.
Antibody to bRII (cat. no. SC 220; Santa Cruz Biotechnol- that was specifically bound. A Scatchard analysis of data
(Fig. 2, insert) indicated that a single class of high-affinityogy) was raised against a peptide corresponding to amino
acids 550 to 565 mapping within the carboxy terminus binding sites was responsible for the binding and that
high-glucose exposure increased the amount of TGF-b1of the precursor form of human bRII that differs from
the corresponding rat sequence by a single residue. These bound at saturation, but did not alter the slope of the
binding curve [35]. Analysis of data from six separateantibodies show no cross-reactivity on Western blots.
experiments yielded 6755 6 1465 high-affinity receptors
Statistical analysis per cell, with an apparent dissociation constant (Kd) of
15.4 6 1.74 pm under normal glucose conditions. TheData were expressed as means 6 sem. Unless otherwise
noted, differences between two groups were evaluated number of receptors per cell increased 50% to 10,178 6
2418 (N 5 6, P 5 0.03) following exposure to high glu-using paired Student’s t-test. In the case in which results
in these groups were normalized according to the control cose. There was, however, no significant change in the
binding affinity (8 mm, 15.4 6 1.74; 35 mm, 25.1 6 5.1,value (100%), the data were analyzed using a one-sample
t-test with a hypothesized mean of 100% to compare the N 5 6, P 5 0.06). The observed change was not due to
an osmolar effect. In separate experiments performedtest group with the control. A paired two-sample t-test
was used to examine differences between the three test under identical conditions, the receptor number and ap-
parent Kd of MCs incubated in medium containing 5 mmgroups. In both cases, a Holm’s test was then applied
post hoc to adjust for multiple comparisons [34]. glucose plus 30 mm mannitol were not different from
those incubated in 5 mm glucose alone (93.1 6 8.6% and
96.4 6 11.5%, respectively, of control, N 5 4, P . 0.5).
RESULTS
In addition, the increase in receptor number was not
TGF-b1 binding kinetics and the effect of glucose the result of a high-glucose–induced change in culture
concentration or cyclic strain density, as the final cell number in the two groups was
not different (8 mm, 2.21 3 105/culture; 35 mm, 2.24 3We first examined the effect of time on 125I-TGF-b1
binding in control, 8 mm glucose-incubated MCs. Specific 105/culture, P 5 0.84) under the culture conditions se-
lected. In preliminary experiments, it was shown thatbinding was time dependent, reaching a maximum after
120 minutes at 228C (Fig. 1). Therefore, subsequent stud- the long-term culture of MCs in 30 mm glucose resulted
in a reduction in cell replication and changes in receptories were carried out using a 120-minute binding period.
Next, MCs cultured in 8 or 35 mm glucose-containing expression. MCs seeded at increasing densities and stud-
ied after four days demonstrated a significant (R 5 0.729,media were examined for binding characteristics with in-
creasing concentrations of 125I-TGF-b1. Binding occurred P 5 0.0009, N 5 17), inverse relationship between the cell
number (3500 to 21,000 receptors per cell) and number ofin a concentration-dependent manner over the range of
Riser et al: Glucose, stretch, and TGF-b receptors432
Fig. 2. Concentration-dependent 125I-TGF-b1
binding and the effect of high glucose treat-
ment. Values shown represent specific bind-
ing, that is, the difference between total binding
of 125I-TGF-b1 and binding in the presence of
100-fold excess unlabeled transforming growth
factor-b (TGF-b) and are from a representa-
tive experiment. (Inset) Scatchard plot of data.
Treatments were either 8 mm (s) or 35 mm
glucose (d).
Fig. 3. Effects of cell stretching on concentra-
tion-dependent 125I-TGF-b1 binding. The assay
was carried out as described in Figure 2, except
mesangial cells (MCs) grown in 8 mm glucose
were subjected to 48 hours of cyclic stretch or
control, static conditions. Results are from a
representative experiment. (Inset) Scatchard
plot of data. Treatments were static (s) and
stretch conditions (d).
calculated TGF-b receptors over a range of 0.5 to 3.5 Scatchard analysis of the data (Fig. 3, inset) indicated
that this change was due to an increase in the numbercells/well.
To next determine if mechanical strain could alter of receptors and was not attributable to altered binding
affinity. Analysis of data from four separate experimentsTGF-b1 binding, MCs grown in 8 mm glucose medium
were subjected to 24 hours of cyclic stretching. This treat- demonstrated a modest, but significant, 10% increase
(static, 11,007 6 1302; stretch, 12,091 6 1473, P 5 0.039)ment increased 125I-TGF-b1–specific binding (Fig. 3). The
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equivalent in all three receptor types. Additional experi-
ments produced similar results after 24 and 72 hours of
stretch (not shown).
Effect of high glucose and cyclic stretching on bRI
and bRII mRNA levels
The cross-linking studies demonstrated that the en-
hanced binding in response to high glucose and stretch
involved multiple TGF-b receptors. To determine if this
correlated to the message levels for these receptors, MCs
grown in either 8 or 35 mm glucose-containing media and
exposed to 48 hours of cyclic stretching, or static condi-
tions, were subjected to Northern analysis and were probed
for bRI or bRII. MCs contained transcripts for both ofFig. 4. Electrophoretic protein gel analysis of 125I-TGF-b1 cross-linked
these receptors (Fig. 6). High glucose, as well as mechani-to mesangial cell receptors. Binding assays on mesangial cells (MCs)
grown in 8 or 35 mm glucose were performed in duplicate, and the bound cal strain, induced a 30 to 50% increase in the level
125I-TGF-b1 was cross-linked to receptors. Cultures were incubated with of bRI mRNA (Fig. 6A). As observed in cross-linkingradiolabeled transforming growth factor-b1 (TGF-b1; A), or radiolabeled
studies, the two stimuli applied in combination failed toplus 100-fold excess unlabeled TGF-b1 (B). A representative autoradio-
gram shows three specifically labeled bands observed at 65, 85, and produce an additive or synergistic effect. Message levels
200 kDa, corresponding to the TGF-b types I, II, and III receptors of bRII were also increased by high glucose or stretchingcomplexes, respectively.
with changes mirroring those of bRI (Fig. 6B).
Modulation of bRI and bRII protein expression
determined by immunocytochemistryin the number of receptors. This occurred in the absence
of changes in the apparent Kd (static, 5.29 6 1.9; stretch, The results discussed earlier in this article indicated
that increased expression of multiple TGF-b receptor6.08 6 2.8, P 5 0.43) or cell number (static, 1.29 3 10 5/
culture 6 0.245; stretch, 1.24 6 0.219, P 5 0.35). types, rather than altered binding affinity, accounts for
the increase in ligand binding induced by high glucose
Modulation of TGF-b receptor types by high glucose and stretch. If this were the case, increased quantities of
and stretch, determined by cross-linking cell-associated receptor protein in response to the stimuli
should be present and might therefore be visualized byThe kinetic studies indicated that increased binding
resulted from an up-regulation in receptor number. This immunofluorescent labeling. Laser confocal microscopy
showed that antibodies to bRI bound MCs, producing acould involve one or more of the TGF-b receptor types.
To identify those receptors responsible, MCs grown in punctate, but homogeneous distribution of fluorescence
throughout the cell (Fig. 7A). High-glucose exposure8 or 35 mm glucose-containing media were incubated with
100 pm 125I-TGF-b1, both with and without 100-fold excess increased the overall number of antibody-labeled foci,
but did not alter their distribution (Fig. 7B). The patternof unlabeled TGF-b1, followed by cross-linking of the li-
gand to the binding molecule(s). Three specifically labeled for bRII labeling was similar but was more diffuse than
that for bRI (Fig. 7C). As was the case for bRI, bRIIbands were observed at 66, 85, and 200 kDa corresponding
to the TGF-b type I, II, and III receptor complexes, re- staining was similarly augmented by high-glucose expo-
sure (Fig. 7D). This effect was confirmed by quantitativespectively (Fig. 4). Each complex represents the receptor
with an attached monomer of TGF-b1 (12 kDa). Expo- image analysis, with an 83 and 62% elevation over con-
trol in bRI and bRII labeling, respectively (Fig. 8).sure to high glucose increased the amount of TGF-b1
receptor complex in all three types (Fig. 4). This binding Cells grown in low-glucose–containing media were
also subjected to various intervals of mechanical strainwas specific because the addition of unlabeled TGF-b
eliminated measurable labeled TGF-b1 binding. and were then fixed and studied by immunocytochemis-
try. Because in this system the stretching force is notNext, quantitative changes in binding among these recep-
tors, both in response to increased glucose and/or to cyclic uniform, but increases are toward the periphery of the
well, we examined cells in the same outermost zone ofstretch, were investigated. The amount of 125I-TGF-b1
receptor complex in all three types was increased by culture after 0 to 96 hours of stretching. bRI expression
was substantially up-regulated by 48 hours of cyclic stretcheither high glucose or 48 hours of cyclic strain, but did
not demonstrate an additional increase when exposed and then appeared to diminish with longer periods of
stretch (Fig. 9) but still remained significantly elevatedto both stimuli (Fig. 5). The increase mediated by stretch
was moderate (25 to 50%) as compared with that of above control levels even after 96 hours. In the same
experiments, bRII labeling was also increased by 48 hoursglucose (100 to 250%), and the observed response was
Riser et al: Glucose, stretch, and TGF-b receptors434
Fig. 5. Effect of high glucose or mechanical strain on transforming growth factor-b1 (TGF-b1) binding to specific receptors. The intensities of
bands corresponding to bRI, bRII, and bRIII from five to seven cross-linking experiments were quantitated following optical scanning. Mesangial
cells (MCs) were grown in normal or high glucose medium and were subjected to stretch ( ) or static (h) conditions. *P , 0.05 vs. static, 8 mm
control. **P , 0.05 vs. stretch, 8 mm.
Fig. 6. Northern blot analysis of mRNA for bRI and bRII after exposure to cyclic stretch and/or high-glucose medium. A single band was detected
corresponding to (A) bRI (6.0 kb) or (B) bRII (5.5 kb), shown from a representative experiment (upper panel). Quantitative image analysis of
band intensities from four (bRI) or seven (bRII) experiments (lower panel); static (h) or stretched ( ) cultures. Results shown were normalized
to the sum of 18S and 28S ribosomal RNAs. *P , 0.002 vs. static, 8 mm control.
of stretching. The magnitude of the change was lower the end of this period, whereas RII protein in the center
than for bRI, yet it remained stable over time. As with of the well decreased 49% (P , 0.05) over the same time.
bRI, although the intensity of staining increased with
stretching, there was no discernible change in the cellular
DISCUSSIONpattern or distribution of the immunoreactive protein
The primary goal of this study was to determine the(data not shown). This induction of receptor protein
effects of high glucose and cyclic mechanical strain onappeared primarily localized to the cells experiencing
modulation of TGF-b receptor activities. First we showedthe greatest force, because cells present in the center of
the well increased TGF-bRI staining 35% (P , 0.05) by that TGF-b1 binding was time- and concentration-
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Fig. 7. Immunofluorescent localization of bRI and bRII protein in mesangial cells (MCs). Following growth in 8 mm (A, C) or 35 mm (B, D, E)
glucose, cells were fixed and examined by laser scanning confocal microscopy for localization of bRI (A, B) or bRII (C, D). A negative control
consisted of substitution of the primary antibody with rabbit nonimmune IgG (inset E). Representative photos are shown.
dependent with MCs expressing approximately 6750 observed, as did Wakefield et al, that cell density was
an important determinant of receptor binding [36].high-affinity (apparent Kd 5 25 pm) receptors per cell
when grown to near confluency. Our findings are compa- Therefore, our studies of receptor modulation by high
glucose and mechanical strain were run under conditionsrable to those of Wakefield et al, who tested a wide
variety of cell types [36], and of MacKay et al, who that were established to produce equivalent final cell
densities in the control and treated groups. Our cross-examined mouse MCs [37]. The former reported a range
of 600 to 40,000 high-affinity receptors per cell, with Kd linking studies demonstrated that the observed specific
binding of TGF-b was to three major proteins, corre-values ranging from 1 to 60 pm, whereas the latter re-
ported 3900 receptors per MC with a Kd of 5 pm. We sponding to bRI, bRII, and bRIII. In addition, MCs
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Fig. 8. Effect of increased glucose on the expression of bRI and bRII
protein. Quantitative image analysis measurements were obtained from
the same set of experiments represented in Figure 7. Images used for
quantitation were constructed from all of the 0.5 mm serial sections
contained in the cell layer with fluorescent signal. Bars indicate the
mean of measurements in eight separate areas, each containing 10 to
20 cells. *P , 0.05 vs. 8 mm control.
expressed mRNAs for bRI and bRII and demonstrated
a homogenous cytoplasmic distribution of the corre-
sponding protein as determined by immunocytochemis-
Fig. 9. Effect of cyclic stretching on the expression of bRI and bRII
try. The expression of mRNA and protein for bRIII was protein. Mesangial cells (MCs) grown in 8 mm glucose-containing media
were subjected to static or stretch conditions for the times indicated.not examined in this study because of the scarcity of
Cell layers were then subjected to immunocytochemical analysis andspecific reagents. Others have reported the presence, in
measurements of receptor expression determined as in as in Figure 8.
rat glomeruli, of two TGF-b–binding proteins equivalent *P , 0.05 vs. static control. **P , 0.05 vs. 96 hours of stretch.
to bRII and bRIII (85 and 200 kDa) [38].
The exposure of MCs to high-glucose concentrations
for a total of 10 to 12 days increased overall specific by high-glucose exposure. As was the case for glucose,
binding, a change caused by a 50% increase in receptor stretch also increased the amount of ligand associated
number. Although not statistically significant, we also with the three receptors types and was accompanied
observed a 63% increase in the mean apparent dissocia- by a corresponding elevation of receptor mRNA and
tion constant, suggesting that a simultaneous reduction protein. A somewhat greater induction by stretch of mes-
in the binding affinity cannot be totally ruled out. How- sage and protein expression was observed for bRI, in
ever, it is likely that this difference can be attributed to comparison to bRII. This difference may have been re-
the interexperimental variability in the calculated affini- lated to the period studied, because our observations of
ties. Nevertheless, protein cross-linking analysis of 125I- protein expression showed a decrease in the magnitude
TGF-b bound to RI, RII, and RIII indicated that, at the of induction with stretching time. By 96 hours, the degree
concentration of ligand used, the net result is increased of elevation of bRI protein was nearly equivalent to
binding. The finding that high-glucose treatment in- bRII. A differential response of these two receptors was
creased to similar levels mRNA transcripts for bRI and not observed following exposure to high-glucose concen-
bRII as well as the immunoreactive receptor proteins trations. Another difference in the response to the two
indicates that the observed increase in binding may result stimuli was in the magnitude of the increase. The greater
from elevated synthesis of the receptors. induction of binding by high glucose, as compared with
Cyclic mechanical force also increased receptor bind- stretch, may also be time dependent; however, this issue
was not examined in these studies.ing, a change that was qualitatively similar to that induced
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In no case was there an additive or synergistic effect this is not a likely mechanism for the observed effects
when both stimuli were applied. This finding is in contrast of high glucose and stretch in this study. Although there
to our previous observations on TGF-b production and are rare reports of renin production in MCs [41, 42], it
collagen synthesis in response to these same treatments is questionable whether this results in the generation of
[13, 15]. In those studies, although stretching or high- angiotensin II in tissue culture. We have observed that
glucose exposure increased TGF-b1 secretion twofold treatment of MCs with the angiotensin-converting enzyme
and the corresponding mRNA levels by 30 to 45%, the inhibitor ramipril failed to alter either the baseline colla-
combination of both stimuli enhanced TGF-b1 secretion gen synthesis in static, control cells or the collagen pro-
greater than fivefold. The significance of this synergistic duction stimulated by stretch (unpublished observation).
effect on TGF-b1 secretion was indicated by the greater Given our understanding that a ternary complex of
stretch-induced collagen accumulation that occurred bRI, bRII, and the ligand is required for signaling, an
when high glucose was also present [13, 15]. This increase up-regulation of both receptors may be required for in-
was totally blocked by the neutralization of all mamma- creased responsiveness [16]. However, there is evidence
lian forms of TGF-b with specific antibodies. In the ab- suggesting otherwise. We have successfully transfected
sence of high-glucose concentrations, collagen synthesis MCs with a dominant negative mutant bRII that lacks
was increased by stretch, but due to a corresponding the cytoplasmic serine/threonine kinase domain but re-
increase in breakdown, collagen accumulation was not tains the ability to bind TGF-b. Overexpression of this
enhanced. Taken together, these studies suggest that the mutant bRII blocked the growth inhibitory effects of
mechanisms for induction of TGF-b1 production are un- TGF-b, but failed to block the induction of collagen type I
like those for induction of TGF-b receptors. It may be and fibronectin mRNA (abstract; Choi et al, J Am Soc
that increased numbers of TGF-b1 receptors, although Nephrol 8:493A, 1997). This differential induction indi-
important in the degree of the metabolic response to cates alternative signaling pathways for different re-
the ligand, particularly when the amount of TGF-b is sponses and suggests that increased activity of one of
overabundant, may not be responsible for the combined the two signaling receptors may be sufficient to alter
effects of stretch and high glucose on collagen accumula- specific responses. The function of bRIII is not clear,
tion that was previously observed. but it appears to present TGF-b to bRII, which then
The precise mechanism(s) for the increase in TGF-b allows increased interaction of bRII and the ligand with
receptor activity is not yet understood. Although it is the signaling receptor [18]. The observed increase in
possible that the increase in active TGF-b, occurring as
bRIII with high glucose or stretching suggests that it too
a response to high glucose or stretch, could be a direct may be involved in the induction of ECM synthesis.
modulator of TGF-b receptors, published studies suggest
The findings from these in vitro experiments may bethat this is not likely the case [39]. For example, in human
relevant in vivo. Hyperglycemia is an established causallung carcinoma cells [36] and in rat kidney fibroblasts [32],
factor in diabetic glomerulosclerosis [43, 44] and mayshort-term incubation with exogenous TGF-b down-reg-
exert its actions, at least in part, by its direct effects onulates, rather than increases, the number of TGF-b re-
the MCs [11]. This is supported by extensive evidenceceptors. There are little data available concerning the
showing that increased concentrations of glucose, similarlong-term effects of TGF-b on the modulation of recep-
to those employed in this study, stimulate ECM accumu-tor expression. However, Wakefield et al, in a compari-
lation by MCs in culture [7–9, 45]. Glomerular hyperten-son of 12 different human and rodent cell lines, found
sion is a second major causal factor in glomerulosclerosisno relationship between the amount of TGF-b secreted
[46, 47]. The observations made in this study using cyclicand the number of TGF-b receptors expressed [36]. Our
mechanical strain in tissue culture are relevant to patho-findings, in this study, of an additive response to mechan-
physiological forces that occur in vivo as a result of in-ical strain and high-glucose levels of increased TGF-b,
creased glomerular pressure. Our studies on the elasticitywithout similar additive changes in TGF-b receptors,
of isolated perfused glomeruli have demonstrated thatalso support this idea. Verification of this lack of relation-
the degree of stretching used in these studies may beship between the cytokine and the expression of its recep-
similar to that in the glomerular mesangium during ex-tor may be difficult, as cultured MCs produce and activate
perimental diabetes [14, 44]. In normal glomeruli, effec-abundant amounts of TGF-b, even in the absence of stim-
tive autoregulation at the afferent arteriole protectsulation by high levels of glucose or stretching. A blockade
against exposure to significant variations in systemicof TGF-b over this period would alter a large number
blood pressure and the resulting distention [48, 49]. How-of cellular events, including cell replication, adhesion,
ever, in experimental diabetes [50] and in remnant glo-and production of matrix, which may be expected to be
meruli after extensive renal ablation [51], the loss ofassociated with altered TGF-b binding.
autoregulation results in the transferal to the glomerularAngiotensin II appears to stimulate ECM synthesis
capillaries of the large (up to 55 mm Hg) moment-to-through the induction of TGF-b [40] and may also be a
factor in the up-regulation TGF-b receptors. However, moment variations in systemic blood pressure [52]. As
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